Literature DB >> 31151415

Case reports: novel TUBG1 mutations with milder neurodevelopmental presentations.

Yue T K Yuen1, Ilaria Guella2, Elke Roland3, Michael Sargent4, Cyrus Boelman5.   

Abstract

BACKGROUND: Tubulinopathies result from mutations in tubulin genes, including TUBG1, responsible for cell microtubules, are characterized by brain development abnormalities, microcephaly, early-onset epilepsy, and motor impairment. Only eleven patients with TUBG1 mutations have been previously described in literature to our knowledge. Here we present two new patients with novel de novo TUBG1 mutations and review other cases in the literature. CASE PRESENTATIONS: Both patients have microcephaly and intellectual disability. Patient B further fits a more typical presentation, with well-controlled epilepsy and mild hypertonia, whereas Patient A's presentation is much milder without these other features.
CONCLUSION: This report expands the spectrum of TUBG1 mutation manifestations, suggesting the possibility of less severe phenotypes for patients and families, and influencing genetic counselling strategies.

Entities:  

Keywords:  Epilepsy; Intellectual disability; Malformations of cortical development; Microcephaly; TUBG1; Tubulin

Mesh:

Substances:

Year:  2019        PMID: 31151415      PMCID: PMC6545025          DOI: 10.1186/s12881-019-0827-6

Source DB:  PubMed          Journal:  BMC Med Genet        ISSN: 1471-2350            Impact factor:   2.103


Background

Mutations in the tubulin genes (e.g. TUBA1A, TUBB2A, TUBA8, TUBB2B, TUBB3, TUBB5, TUBG1) are associated with a range of brain malformations. Common tubulinopathic presentations include an array of lissencephalies, polymicrogyria-like cortical dysplasia, simplified gyral pattern, microlissencephaly, and a dysmorphic corpus callosum [1, 2]. Eleven patients with a TUBG1 mutation have been described in the literature to our knowledge, and only limited clinical information is available for these patients. They are described with microcephaly, motor impairment, intellectual disability and epilepsy [1, 3, 4]. Here we report two further patients with novel TUBG1 mutations and milder presentations.

Case presentations

These two patients are followed at BC Children’s Hospital, a public academic tertiary pediatric referral centre, serving a population of nearly 5 million people. Patient A is a 10-year old right-handed female born following a pregnancy complicated by antenatal microcephaly noted on fetal ultrasound. She is of Chinese descent and has no family history of consanguinity or congenital anomalies. Her early development milestones were normal; she sat at 6 months, crawled at 8 months and walked at 12 months of age. Her mild intellectual disability was first apparent at the age of six years and she is now two years behind her peers academically, with no regression in development. She speaks two languages. She has an independent education plan. At birth her head circumference was not measured and by ten years of age the patient’s head circumference was 46 cm (2 SD below the mean). She has some dysmorphic facial features including prominent ears relative to her microcephaly, a tented mouth, and bilateral 5th finger clinodactyly. Neurological examination was otherwise unremarkable. Magnetic resonance imaging (MRI) at nine years of age revealed microcephaly, posteriorly predominant simplified cortical gyri, and areas of band and nodular heterotopia (Fig. 1). No seizure-like activity has been described by the parents but a screening electroencephalogram (EEG) demonstrated occasional interictal sharp waves over the right central temporal areas in drowsiness and sleep, suggestive of a predisposition towards focal onset seizures, in addition to occasional, non-specific, generalized paroxysmal delta activity in sleep. Chromosomal microarray and biochemical screening for inborn errors of metabolism (as described elsewhere) were both unremarkable [5]. Clinical whole exome sequencing (Centogene AG, Rostock, Germany) revealed a novel, de novo TUBG1 missense mutation (NM_001070.4: c.202G > A; p.Asp68Asn), using a trio approach (proband plus parents), chosen due to the multiple potential causative genes. The parents consented to this report.
Fig. 1

MRI Findings of Patient A with TUBG1 p.Asp68Asn mutation and Patient B with TUBG1 p.Arg341Trp mutation. a Sagittal T1-weighted MPRAGE image demonstrates reduced craniofacial ratio in this child with microcephaly and posteriorly predominant simplified cortical gyri. The cerebellar vermis is normal. The corpus callosum appears slightly thick. b and c Coronal (b) T1 weighted MPRAGE and (c) Coronal T2 weighted fast spin echo images demonstrating bilateral parietal band heterotopia, more pronounced on the left (arrow). d Axial T1 weighted MPRAGE image shows bilateral blurring of the grey-white interface along the central sulci, in keeping with focal cortical dysplasia (arrows). e Sagittal T1-weighted image demonstrates microcephaly, intact corpus callosum and normal pituitary. The pons and cerebellar vermis are small for gestational age, but are notably less affected than the supratentorial brain. f and g Coronal (f) and axial (g) T2-weighted images demonstrating dilated lateral ventricles and simplified gyral pattern. In (f) there is prominence of the cerebellar folia but normal-appearing dentate nuclei. In (g) the basal ganglia and thalami are small and poorly defined, with absent myelination of the posterior limb of internal capsule

MRI Findings of Patient A with TUBG1 p.Asp68Asn mutation and Patient B with TUBG1 p.Arg341Trp mutation. a Sagittal T1-weighted MPRAGE image demonstrates reduced craniofacial ratio in this child with microcephaly and posteriorly predominant simplified cortical gyri. The cerebellar vermis is normal. The corpus callosum appears slightly thick. b and c Coronal (b) T1 weighted MPRAGE and (c) Coronal T2 weighted fast spin echo images demonstrating bilateral parietal band heterotopia, more pronounced on the left (arrow). d Axial T1 weighted MPRAGE image shows bilateral blurring of the grey-white interface along the central sulci, in keeping with focal cortical dysplasia (arrows). e Sagittal T1-weighted image demonstrates microcephaly, intact corpus callosum and normal pituitary. The pons and cerebellar vermis are small for gestational age, but are notably less affected than the supratentorial brain. f and g Coronal (f) and axial (g) T2-weighted images demonstrating dilated lateral ventricles and simplified gyral pattern. In (f) there is prominence of the cerebellar folia but normal-appearing dentate nuclei. In (g) the basal ganglia and thalami are small and poorly defined, with absent myelination of the posterior limb of internal capsule Patient B is a 13-month old male born following a pregnancy complicated by fetal ultrasound findings of microcephaly (bitemporal narrowing), possible cavum septum pellucidum, enlarged ventricles, agenesis of the corpus callosum, and lissencephaly. He is of Caucasian descent with no family history of consanguinity or congenital anomalies, but a maternal history of simple febrile seizures and paternal history of asymptomatic Huntington’s disease gene carriers. Head circumference at birth was below the 3rd percentile, (measured as 21 cm at 2 weeks of age), length 10-50th percentile, and weight 10th percentile. Up-slanting palpebral fissures were noted. Within the first hour of life, he experienced a seizure characterized by left-sided clonic activity with secondary bilateral synchrony and oxygen desaturation. This was managed with phenobarbital. The interictal EEG at this point showed diffuse suppression and excessive left central sharp waves, suggestive of cerebral dysfunction with some focality. A full septic workup was completed and negative. MRI at the age of thirteen days demonstrated microcephaly, a small cerebellum, reduced number and complexity of the cerebral sulci and gyri with no cortical thickening or polymicrogyria, general paucity of cerebral white matter, dilated lateral ventricles, a normal third ventricle, small lentiform nuclei which were not well separated from the small thalami, and a grossly normal corpus callosum for age. There was normal myelination in the brainstem and cerebellum but there was lack of myelination in the posterior limbs of internal capsules. The patient had twenty-nine more seizures within the first forty-three days of life. These were twenty to forty seconds in length and generally associated with feeding. They involved a combination of apnea and cyanosis, lip smacking, head turning to the right, left eye deviation, arm flexion, leg extension, and post-ictal fatigue. At last follow-up, seizures were controlled with levetiracetam and topiramate. He has central hypothyroidism on thyroxine but otherwise normal pituitary function. He was also found to have small optic nerves, and a small secundum atrial septal defect shunting left to right. At 13 months, last follow up, he is not yet rolling or sitting independently, but has head control, brings his hands to the midline, is babbling and visually fixing and following. Neurological examination is notable for slightly low axial tone and increased appendicular tone, with a head circumference of 36 cm (below 3rd percentile). Chromosomal microarray and biochemical screening for inborn errors of metabolism were both unremarkable [5]. Clinical whole exome sequencing (GeneDx, Gaitherburg, USA) revealed a novel, de novo TUBG1 missense mutation (NM_001070.4: c1021C > T; p.Arg341Trp) using a trio approach. The parents consented to this report.

Discussion and conclusions

Tubulinopathies are characterized by a wide range of brain malformations, including lissencephaly, polymicrogyria and mildly simplified gyral patterning. The full phenotypic spectrum of tubulinopathies is however not yet fully known. All but one of the eleven reviewed cases of TUBG1 mutations involved epilepsy, majority of which were refractory and early-onset in nature. Of the seven patients with birth head circumference measurements, six had microcephaly (< 2 standard deviations (SD) below the mean) and four of the six had severe microcephaly (< 3 SD below the mean). Motor dysfunction was present in all but one patient out of the nine with the available data, ranging from delayed motor development to spastic tetraplegia. All patients suffered from intellectual disability ranging from moderate to severe [1, 3, 4]. Patient A represents the least severe manifestation of TUBG1 mutation reported so far, having microcephaly, brain malformations, mild facial dysmorphia, and mild intellectual disability, but no motor impairment or epilepsy. Patient B had a more typical presentation sharing features with the more severe phenotype: microcephaly, brain malformations, global development delay and early-onset epilepsy (though easily controlled). Other neurological, clinical, and genetic phenotypes are compared in summary in Table 1.
Table 1

Clinical, imaging, and genetic features of patients with TUBG1 mutations

IDPatient APatient BPatient 11,3Patient 21,3Patient 31,3Patient 44Patient 54Patient 64Patient 74Patient 84Patient 94Patient 104Patient 114
Mutationc.202G > A; p.Asp68Asnc1021C > T; p.Arg341Trpc.1160 T > C; p.Leu387Proc.275A > G; p.Tyr92Cysc.991A > C; p.Thr331Proc.63C > A; p.Phe21Leuc.985G > T; p.Asp329Tyrc.776C > T; p.Ser259Leuc.776C > T; p.Ser259Leuc.776C > T; p.Ser259Leuc.776C > T; p.Ser259Leuc.769A > T; p.Ile257Phec.776C > T; p.Ser259Leu
Mode of inheritanceDe novoDe novoDe novoDe novoFather’s DNA N/ADe novoFather’s DNA N/ADe novoDe novoGermline mosaicism in parentGermline mosaicism in parentDe novoDe novo
Mutation effectAspartate to asparagine within a highly conserved residue in the GTP-binding pocketArginine to tryptophan within a highly conserved residue located in the C-terminal domain that is required for the dimerization of y-tubulinLeucine to proline within a highly conserved residue within an α-helix located in the C-terminal domainTyrosine to cysteine within a highly conserved residue in the vicinity of the GTPase domainThreonine to proline within a highly conserved residue in an α-helix within the γ-γ protein interaction domain located in the C-terminal domainPhenylalanine to leucine within the GTPase domainAspartate to tyrosine within a highly conserved residue in the C-terminal domain. Located on the surface of the TUBG1 proteinSerine to leucine within a highly conserved residue located in the C-terminal domainSerine to leucine within a highly conserved residue located in the C-terminal domainSerine to leucine within a highly conserved residue located in the C-terminal domainSerine to leucine within a highly conserved residue located in the C-terminal domainIsoleucine to phenylalanine within a highly conserved residue located in the C-terminal domainSerine to leucine within a highly conserved residue located in the C-terminal domain
SexFMFMFMMFFFMMF
Age at follow-up10y6mo21y18mo31y33y21y19mo14y11y 6mo9y 6mo15y18mo
Head circumference<−2.1 SD<−1.9 SD<−5.5 SD<−4 SD<−1 SD57 cm53.1 cm (<−2.6 SD)<−3.5 SDN/A47.5 cm at 6y 6mo (<−3.3 SD)N/A51.3 cm at 13y (<− 2.5 SD)N/A
EpilepticNoYesYesYesYesYesYesNoYesYesYesYesYes
Seizure age of onset< 1 h of lifeEarly-onsetN/AEarly-onset36moN/A6mo4moN/A3y 11mo5mo
Type of seizuresFocal with secondary bilateral synchronyN/AInfantile spasmsN/ATonic-atonic-myoclonicPartial complex; versive, myoclonicTonic-clonicGeneralized tonic-clonicN/AN/AFocal, versive
Refractory epilepsyNoYesYesYesN/AYesN/AN/AN/AN/ANo
Motor dysfunctionNoMild axial hypotonia; appendicular hypertoniaSpastic tetraplegia (bedridden)Spastic tetraplegia (bedridden)Moderate cerebral palsySpastic tetraplegia (walks with support)Spastic tetraplegiaDelayed motor developmentUnsteady gaitSpastic diplegiaN/AN/ADelayed motor development
IDModerateModerate global delaySevereSevereModerateSevereSevereN/AN/AModerateModerateModerate (FS IQ-score 44)Severe
Speech and Language DevelopmentNormalModerate global delayN/AN/AN/AOnly sounds, no speechNon-verbalDelayedNon-verbal50 wordsNon-verbal5–6 word sentencesNon-verbal
Age at MRI9y13 daysN/AN/AN/A36y11y1y 6mo12mo13y 7mo2mo6y9y
Cortical dysgenesis (MRI)Posterior predominant pachygyria, band heterotopia, nodular heterotopiaReduced cortical sulci and gyriSevere posterior predominant pachygyria/agyria (posterior agyria, frontal pachygyria), thick cortexSevere posterior predominant pachygyria/agyria (posterior agyria, frontal pachygyria), thick cortexPosterior pachygyria, moderate posterior subcortical band heterotopiaPosterior predominant pachygyria (posterior frontal lobe and parieto-occipital cortex)Diffuse agyriaPosterior predominant pachygyria (mild over frontal lobes, moderate over posterior lobes), cortex 10-13 mm thickPosterior predominant pachygyria, sparse cells over occipital lobes, cortex 13-15 mm thickPosterior predominant pachygyria (mild over frontal lobe, moderate over temporal and occipital lobes), cortex 6-13 mm thickPosterior predominant pachygyria (mild over frontal lobe, moderate over temporal and occipital lobes), cortex > 15 mm thickPosterior predominant pachygyria (almost normal over frontal lobes, pachygyria over perisylvian and occipital lobes), cortex 6-10 mm thickPosterior predominant pachygyria (mild over frontal lobe, moderate over temporal and occipital lobe, deep parietal lobe infolding)
Corpus callosum (MRI)Normal-ThickNormalThinThick, dysmorphicThick, dysmorphicNormalThinNormalNormalNormalThinNormalThin
Other MRI FindingsGeneral paucity of white matter, small cerebellum, dilated lateral ventricles, small lentiform nuclei, small thalami, posterior limbs of internal capsule lacking myelinationMildly enlarged lateral ventricles, mildly reduced white matterMildly enlarged lateral ventricles, severely reduced white matterEnlarged perivascular spaces, enlarged posterior horns of lateral ventricles, hippocampal malrotationSeverely enlarged lateral ventricles, severely reduced white matter, dysplastic basal ganglia, hypoplastic brainstem, hypoplastic vermisMildly enlarged lateral ventricles, mildly reduced white matterMildly enlarged lateral ventricles, mildly reduced white matterEnlarged posterior horns of lateral ventriclesMildly enlarged lateral ventriclesMildly enlarged posterior horns of lateral ventricles, mildly reduced white matterMildly enlarged lateral ventricles, mildly reduced white matter, dysplastic basal ganglia

F female, M male, y years, mo months, SD standard deviation, ID intellectual disability, − absent, N/A not available

Clinical, imaging, and genetic features of patients with TUBG1 mutations F female, M male, y years, mo months, SD standard deviation, ID intellectual disability, − absent, N/A not available Whereas tubulin gene mutations often follow an autosomal dominant mode of inheritance [2], TUBG1 mutations are almost entirely de novo [1, 3, 4]. Furthermore, tubulinopathies encompass a range of phenotypes including extreme lissencephaly, severe cerebellar hypoplasia, and varying cortical thickness [6, 7]. Despite overlap between the brain phenotypes of different tubulinopathies, certain phenotypes are associated with specific tubulin genes [8]. TUBG1 patients, are characterized by pachygyria/agyria that is most intense in the parieto-occipital regions with a posterior to anterior gradient as well as enlarged lateral ventricles and reduced white matter volume [3, 4]. Lastly, unlike other tubulinopathies, majority of TUBG1 mutation patients have a normal cerebellum, basal ganglia, and brainstem [1, 4]. Patient A coincides with the known TUBG1 presentation involving posteriorly-predominant pachygyria and a normal cerebellum, basal ganglia, and brainstem. However, this patient diverges from the known TUBG1 mutation phenotype due to the presence of band and nodular heterotopia, normal white matter volume, and normal lateral ventricle size. Patient B is similar to known TUBG1 mutation in having pachygyria (although not posteriorly-predominant), dilated lateral ventricles, reduced white matter, normal cerebellum, and brainstem. Unlike typical TUBG1 mutation phenotype, this patient has a small cerebellum. In consideration of the microcephaly spectrum, radiologically, Patent B may correspond to a label of congenital microcephaly with a simplified gyral pattern [9]. TUBG1 encodes for γ-tubulin, highly expressed in the developing fetal brain as a component of centrosomes. It plays an integral role in microtubule nucleation, thereby affecting microtubule-dependent mitosis and brain development [3, 4]. Poirier et al. introduced mutations in the γ-tubulin gene (tub4) in S. cerevisiae which interfered with microtubule nucleation. Suppression of TUBG1 in utero of mice also arrested neuronal migration [3]. Depending on the mutation locus, the different TUBG1 mutations are thought to have an effect on γ-tubulin structure or function. It is suspected that TUBG1 mutations affect neuronal migration hence MRI findings showing pachygyria/agyria. This is in comparison to other tubulinopathies which are more associated with polymicrogyria or dysgyria [4]. We suspect the TUBG1 mutations found to be likely pathogenic. Both missense mutations described in this paper were de-novo resulting in substitutions in highly conserved amino acids which are predicted to be damaging by multiple in-silico algorithms, including SIFT, PolyPhen-2, MutationTaster2. Neither mutation has been reported in public databases (gnomAD Browser), and two likely pathogenic entries are present in ClinVar for the Arg341 residue (Patient B). The p.Asp68Asn mutation (Patient A) affects a highly conserved residue in all 20 human tubulin proteins and their ancestral homologs. The Asp68 residue is located in the GTP-binding pocket and together with the Glu72 coordinates the Mg2+ ion that interacts with the GTP γ-phosphate [10, 11] (Fig. 2). The p.Arg341Trp mutation (Patient B) substitutes a positively-charged arginine with an aromatic amino-acid, within the Tubulin/FtsZ 2-layer sandwich (or C-terminal) domain (Fig. 2). The Arg341 residue is part of a stretch of polar amino acids (Arg339, Arg341, Glu342, Arg343 and Lys344) at the interface of γ–γ tubulin dimer and plays a critical role in the in assembly of the γ tubulin homodimer by forming multiple H-bonds with residue Asp252 on the opposite chain [12].
Fig. 2

TUBG1 Mutations in Individuals with Refractory Early-Onset Epilepsy. Top: crystal structure of γ-tubulin. Dimeric γ-tubulin is shown as ribbons, and the GTP bound molecule is shown as stick (PDB ID: 3CB2 [13]). Mutated residues, identified in this study (green) are shown. Right: close-up view of the GTP-binding pocket. Left: close-up view of the γ-γ dimer interface. GTP molecule and interacting residues are shown in stick representation, the Mg2+ ion as a sphere, and hydrogen bonds as green dashed lines (PDB ID: 1Z5V [7]). Images were generated using PyMOL. Bottom: partial sequence alignment of TUBG1 orthologs and different human tubulin proteins surrounding the Asp68 mutated residue. Identical residues across all proteins are shown in black, and residues identical to the human TUBG1 are in gray. GenBank accession numbers are as follows: Homo sapiens, NP_001061.2; Mus musculus, NP_598785.1; Gallus gallus, XP_015155127.1; Xenopus tropicalis, NP_001072509.1; Dario rerio, NP_957202.1; Caenorhabditis elegans, NP_499131.1; Arabidopsis thaliana, NP_191724.1; human TUBA1A, NP_001257328.1; human TUBA8, NP_061816.1; human TUBB, NP_001280141.1; human TUBB2A, NP_001060.1; human TUBB2B, NP_821080.1; TUBB3, NP_006077.2; and human TUBB4A, NP_001276052.1. Sequences were aligned with CLUSTAL Omega.32 Asterisks indicate positions with a single fully conserved residue, colons indicate conservation between groups with strongly similar properties, and periods indicate conservation between groups with weakly similar properties

TUBG1 Mutations in Individuals with Refractory Early-Onset Epilepsy. Top: crystal structure of γ-tubulin. Dimeric γ-tubulin is shown as ribbons, and the GTP bound molecule is shown as stick (PDB ID: 3CB2 [13]). Mutated residues, identified in this study (green) are shown. Right: close-up view of the GTP-binding pocket. Left: close-up view of the γ-γ dimer interface. GTP molecule and interacting residues are shown in stick representation, the Mg2+ ion as a sphere, and hydrogen bonds as green dashed lines (PDB ID: 1Z5V [7]). Images were generated using PyMOL. Bottom: partial sequence alignment of TUBG1 orthologs and different human tubulin proteins surrounding the Asp68 mutated residue. Identical residues across all proteins are shown in black, and residues identical to the human TUBG1 are in gray. GenBank accession numbers are as follows: Homo sapiens, NP_001061.2; Mus musculus, NP_598785.1; Gallus gallus, XP_015155127.1; Xenopus tropicalis, NP_001072509.1; Dario rerio, NP_957202.1; Caenorhabditis elegans, NP_499131.1; Arabidopsis thaliana, NP_191724.1; human TUBA1A, NP_001257328.1; human TUBA8, NP_061816.1; human TUBB, NP_001280141.1; human TUBB2A, NP_001060.1; human TUBB2B, NP_821080.1; TUBB3, NP_006077.2; and human TUBB4A, NP_001276052.1. Sequences were aligned with CLUSTAL Omega.32 Asterisks indicate positions with a single fully conserved residue, colons indicate conservation between groups with strongly similar properties, and periods indicate conservation between groups with weakly similar properties We present here two patients each with a novel, de novo TUBG1 mutation with common features of microcephaly and intellectual disability but lacking both spastic tetraplegia and more severe refractory epilepsy. The especially mild phenotype of patient A expands the spectrum associated with TUBG1 mutations and will provide a much different perspective in genetic counselling to families moving forward. However, further work is needed to more fully understand genotype-phenotype correlations in this rare genetic disorder.
  12 in total

1.  Insights into microtubule nucleation from the crystal structure of human gamma-tubulin.

Authors:  Hector Aldaz; Luke M Rice; Tim Stearns; David A Agard
Journal:  Nature       Date:  2005-05-26       Impact factor: 49.962

2.  Early identification of treatable inborn errors of metabolism in children with intellectual disability: The Treatable Intellectual Disability Endeavor protocol in British Columbia.

Authors:  Clara Dm van Karnebeek; Sylvia Stockler-Ipsiroglu
Journal:  Paediatr Child Health       Date:  2014-11       Impact factor: 2.253

3.  Molecular insight into γ-γ tubulin lateral interactions within the γ-tubulin ring complex (γ-TuRC).

Authors:  Charu Suri; Triscia W Hendrickson; Harish C Joshi; Pradeep Kumar Naik
Journal:  J Comput Aided Mol Des       Date:  2014-07-17       Impact factor: 3.686

4.  The wide spectrum of tubulinopathies: what are the key features for the diagnosis?

Authors:  Nadia Bahi-Buisson; Karine Poirier; Franck Fourniol; Yoann Saillour; Stéphanie Valence; Nicolas Lebrun; Marie Hully; Catherine Fallet Bianco; Nathalie Boddaert; Caroline Elie; Karine Lascelles; Isabelle Souville; Cherif Beldjord; Jamel Chelly
Journal:  Brain       Date:  2014-06       Impact factor: 13.501

Review 5.  Malformations of cortical development.

Authors:  Rahul S Desikan; A James Barkovich
Journal:  Ann Neurol       Date:  2016-11-11       Impact factor: 10.422

Review 6.  Genetic Basis of Brain Malformations.

Authors:  Elena Parrini; Valerio Conti; William B Dobyns; Renzo Guerrini
Journal:  Mol Syndromol       Date:  2016-08-27

7.  Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly.

Authors:  Karine Poirier; Nicolas Lebrun; Loic Broix; Guoling Tian; Yoann Saillour; Cécile Boscheron; Elena Parrini; Stephanie Valence; Benjamin Saint Pierre; Madison Oger; Didier Lacombe; David Geneviève; Elena Fontana; Franscesca Darra; Claude Cances; Magalie Barth; Dominique Bonneau; Bernardo Dalla Bernadina; Sylvie N'guyen; Cyril Gitiaux; Philippe Parent; Vincent des Portes; Jean Michel Pedespan; Victoire Legrez; Laetitia Castelnau-Ptakine; Patrick Nitschke; Thierry Hieu; Cecile Masson; Diana Zelenika; Annie Andrieux; Fiona Francis; Renzo Guerrini; Nicholas J Cowan; Nadia Bahi-Buisson; Jamel Chelly
Journal:  Nat Genet       Date:  2013-04-21       Impact factor: 38.330

8.  GTP regulates the microtubule nucleation activity of γ-tubulin.

Authors:  Linda Gombos; Annett Neuner; Mykhaylo Berynskyy; Luca L Fava; Rebecca C Wade; Carsten Sachse; Elmar Schiebel
Journal:  Nat Cell Biol       Date:  2013-10-27       Impact factor: 28.824

Review 9.  Tubulin genes and malformations of cortical development.

Authors:  Romina Romaniello; Filippo Arrigoni; Andrew E Fry; Maria T Bassi; Mark I Rees; Renato Borgatti; Daniela T Pilz; Thomas D Cushion
Journal:  Eur J Med Genet       Date:  2018-07-17       Impact factor: 2.708

10.  Tubulinopathies continued: refining the phenotypic spectrum associated with variants in TUBG1.

Authors:  Stefanie Brock; Katrien Stouffs; Emmanuel Scalais; Marc D'Hooghe; Kathelijn Keymolen; Renzo Guerrini; William B Dobyns; Nataliya Di Donato; Anna C Jansen
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

View more
  4 in total

1.  Experiences with offering pro bono medical genetics services in the West Indies: Benefits to patients, physicians, and the community.

Authors:  Andrew K Sobering; Dong Li; Jennifer S Beighley; John C Carey; Tyhiesia Donald; Sarah H Elsea; Karla P Figueroa; Jennifer Gerdts; Andre Hamlet; Ghayda M Mirzaa; Beverly Nelson; Stefan M Pulst; Janice L Smith; Flora Tassone; Helga V Toriello; Ruth H Walker; Katherine R Yearwood; Elizabeth J Bhoj
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-12-04       Impact factor: 3.908

2.  A novel TUBG1 mutation with neurodevelopmental disorder caused by malformations of cortical development.

Authors:  Ru Shen; Zhen Zhang; Yu Zhuang; Xiaohong Yang; Lifen Duan
Journal:  Biomed Res Int       Date:  2021-02-26       Impact factor: 3.411

3.  The phenotypic and transcriptomic effects of developmental exposure to nanomolar levels of estrone and bisphenol A in zebrafish.

Authors:  Chia-Chen Wu; Jeremiah N Shields; Camille Akemann; Danielle N Meyer; Mackenzie Connell; Bridget B Baker; David K Pitts; Tracie R Baker
Journal:  Sci Total Environ       Date:  2020-11-14       Impact factor: 7.963

Review 4.  Microtubule Dynamics and Neuronal Excitability: Advances on Cytoskeletal Components Implicated in Epileptic Phenomena.

Authors:  Giuditta Gambino; Valerio Rizzo; Giuseppe Giglia; Giuseppe Ferraro; Pierangelo Sardo
Journal:  Cell Mol Neurobiol       Date:  2020-09-14       Impact factor: 5.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.